Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Künzel

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Human Heredity|September 6, 2012
Parameter estimation and quantitative parametric linkage analysis with GENEHUNTER-QMODThomas Künzel, Konstantin Strauch
Pharmaceutical Statistics|June 26, 2024
Do You Want to Stay Single? Considerations on Single-Arm Trials in Drug Development and the Postregulatory SpaceYulia Dyachkova, Cornelia Dunger-Baldauf, Nathalie Barbier, et al.
Trials|June 30, 2021
Survival analysis for AdVerse events with VarYing follow-up times (SAVVY)-estimation of adverse event risksRegina Stegherr, Claudia Schmoor, Jan Beyersmann, et al.
Frontiers in Neurology|March 6, 2023
SAkuraBONSAI: Protocol design of a novel, prospective study to explore clinical, imaging, and biomarker outcomes in patients with AQP4-IgG-seropositive neuromyelitis optica spectrum disorder receiving open-label satralizumabJeffrey L Bennett, Kazuo Fujihara, Ho Jin Kim, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Human Heredity|September 6, 2012
Parameter estimation and quantitative parametric linkage analysis with GENEHUNTER-QMODThomas Künzel, Konstantin Strauch
Pharmaceutical Statistics|June 26, 2024
Do You Want to Stay Single? Considerations on Single-Arm Trials in Drug Development and the Postregulatory SpaceYulia Dyachkova, Cornelia Dunger-Baldauf, Nathalie Barbier, et al.
Trials|June 30, 2021
Survival analysis for AdVerse events with VarYing follow-up times (SAVVY)-estimation of adverse event risksRegina Stegherr, Claudia Schmoor, Jan Beyersmann, et al.
Frontiers in Neurology|March 6, 2023
SAkuraBONSAI: Protocol design of a novel, prospective study to explore clinical, imaging, and biomarker outcomes in patients with AQP4-IgG-seropositive neuromyelitis optica spectrum disorder receiving open-label satralizumabJeffrey L Bennett, Kazuo Fujihara, Ho Jin Kim, et al.
Pageof 1